Blog

Among the vastly different ways of tackling a disease, controlling the genetic expression of cells is undoubtedly one of the most powerful. Over the past few decades, scientists have come up with dozens of innovative strategies that involve using messenger RNA (mRNA) to ‘force’ cells

“[…] myeloid neoplasms associated with DDX41 variants likely exhibit a unique pathogenesis that diverges from the conventional understanding of myeloid neoplasms.” Credit: 2024 Matsui. “[…] myeloid neoplasms associated with DDX41 variants likely exhibit a unique pathogenesis that diverges from the conventional understanding of myeloid neoplasms.”

A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails.  .  Credit: UCC A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after

VHIO-led study shows the preclinical promise of systemic targeted therapy in pseudomyxoma peritonei Credit: VHIO VHIO-led study shows the preclinical promise of systemic targeted therapy in pseudomyxoma peritonei   Results of a preclinical, proof-of-concept study led by VHIO’s Stem Cells and Cancer Group demonstrate for

July 18, 2024, Nutley, NJ – The foundational science to develop an exhaled-breath test for detection of lung diseases including lung cancer is underway, according to new research published by a laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI).  Credit: Hackensack Meridian

Manel Esteller, Group Leader at the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Chair of Genetics at the Faculty of Medicine and Health Sciences of the University of Barcelona, has been awarded the Burdinola Research Award. This recognition is granted by the Burdinola

Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs and frailty of the patient’s organ functions. A type of anti-tumor immunotherapy called allogeneic hematopoietic cell transplantation, which can exert anti-cancer effect accompanied by severe

Tackling brain cancer is complicated, but groundbreaking new research could help add another tool to the cancer-fighting arsenal. Credit: Photo by Andrew Mann for Virginia Tech. Tackling brain cancer is complicated, but groundbreaking new research could help add another tool to the cancer-fighting arsenal. A

A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at the U, and Boston University Chobanian & Avedisian School of Medicine found that women with severe endometriosis are 10 times more likely to get ovarian cancer, compared to women

“Novel senomorphic and senolytic agents can be evaluated in this model as they are identified.” Credit: 2024 Spina et al. “Novel senomorphic and senolytic agents can be evaluated in this model as they are identified.” BUFFALO, NY- July 17, 2024 – A new research paper